The replacement of His(4) in angiotensin IV by conformationally constrained residues provides highly potent and selective analogues

J Med Chem. 2009 Sep 24;52(18):5612-8. doi: 10.1021/jm900651p.

Abstract

The histidine residue in angiotensin IV was replaced by various conformationally constrained amino acids. The substitution of the His(4)-Pro(5) dipeptide sequence by the constrained Trp analogue Aia-Gly, in combination with beta(2)hVal substitution at the N-terminus, provided a new stable analogue H-(R)-beta(2)hVal-Tyr-Ile-Aia-Gly-Phe-OH (AL-40) that is a potent ligand for the Ang IV receptor IRAP and selective versus AP-N and the AT1 receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Aminopeptidases / metabolism
  • Angiotensin II / analogs & derivatives*
  • Angiotensin II / chemistry
  • Angiotensin II / metabolism
  • Animals
  • Azepines / chemistry
  • Biomimetics
  • CHO Cells
  • Carboxylic Acids / chemistry
  • Cricetinae
  • Cricetulus
  • Cystinyl Aminopeptidase / metabolism
  • Histidine*
  • Humans
  • Phenylalanine / chemistry
  • Protein Conformation
  • Receptor, Angiotensin, Type 1 / metabolism
  • Substrate Specificity

Substances

  • Azepines
  • Carboxylic Acids
  • Receptor, Angiotensin, Type 1
  • Angiotensin II
  • angiotensin II, des-Asp(1)-des-Arg(2)-Ile(5)-
  • Phenylalanine
  • Histidine
  • Aminopeptidases
  • Cystinyl Aminopeptidase
  • leucyl-cystinyl aminopeptidase